MZEI

 
Common Stock SEC Reporting - Current
OTCQB
Contact Info
  • 4000 Bridgeway
  • Suite 401
  • Sausalito, CA 94965

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000753772
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 5122 - Drugs, proprietaries, and sundries
Incorporated In: NV, USA
Year of Inc. 1984
Employees 4 a/o Sep 24, 2014
Company Officers/Contacts
Edwin G. Marshall CEO
Stephanie Lynn Sorensen CFO
Jill Marshall Director, Ops.
Dr. Michael E. Shannon Medical Director, President
Company Directors
Vincent C Caponi
David A. Esposito
Daniel Hoyt
Edwin G. Marshall
Dr. Michael E. Shannon
Company Notes
  • Formerly=Madison Funding, Inc. to 3-86
Service Providers
Accounting/Auditing Firm
Tanner LLC
215 South State St.
Suite 800
Salt Lake City, UT, 84111
United States

Legal Counsel
Durham, Jones & Pinegar Law
111 East Broadway
Suite 900
Salt Lake City, UT, 84111
United States

Investor Relations Firm
Not Available
MZEI Security Details
Share Structure
Market Value1 $52,708,378 a/o Dec 06, 2016
Authorized Shares 395,000,000 a/o Sep 30, 2016
Outstanding Shares 393,934,068 a/o Nov 10, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record 2,350 a/o Mar 03, 2016
Short Selling Data
Short Interest 61,908 (89.85%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security